Skip to main content

The Wistar Institute

|

Wistar and Peter Mac Scientists Discover Fundamental Mechanism That Fine-tunes Gene Expression and Is Disrupted in Cancer

PHILADELPHIA and MELBOURNE, Australia — (May. 17, 2021) — A team of scientists from The Wistar Institute in Philadelphia and the Peter MacCallum Cancer Center in Melbourne, Australia, discovered a new checkpoint mechanism that fine-tunes gene transc…
Read more
|

Wistar Expands International Training of the Next Generation of Scientists With the University of Bologna

PHILADELPHIA — (April 27, 2021) — The Wistar Institute and the University of Bologna (Unibo) in Italy have established the Wistar-Unibo Ph.D. Exchange Program in Cell and Molecular Biology to bring Unibo graduate students to Wistar for their three-y…
Read more
|

Latest Wistar Discoveries: Fine-tuning Vaccine Delivery in Preclinical Models to Advance MERS DNA Vaccine Candidate and Discovering New Targets for Cancer Therapy

A team of Wistar scientists led by Dr. David Weiner, Wistar executive vice president, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Professor in Cancer Research, and Dr. Ami Pat…
Read more
|

Wistar and Leiden University Medical Center Engage in Collaborative Seminars

Two institutions forge a valuable international collaboration based on training and emerging research alignment. Wistar and Leiden University Medical Center (LUMC) in the Netherlands have started building a scientific bridge by connecting virtually…
Read more
|

Dr. Ebony Gary Received Awards from American Association of Immunologists and American Society of Gene & Cell Therapy

Congratulations to Ebony Gary, Ph.D., postdoctoral fellow from the Weiner lab, for receiving the 2021 AAI Trainee Abstract Award from the American Association of Immunology and having her abstract selected for presentation at Virtual Immun…
Read more
|

Low-dose Administration of MERS DNA Vaccine Candidate Induces Potent Immunity and Protects From Virus Challenge in Preclinical Models

PHILADELPHIA — (April 22, 2021) — A synthetic DNA vaccine candidate for Middle East respiratory syndrome coronavirus (MERS-CoV) developed at The Wistar Institute induced potent immune responses and afforded protective efficacy in non-human primate (…
Read more
|

Wistar Scientists Discover New Mechanism Through Which Senescent Cells Turn On Genes That Encode for Secreted Tumor-regulating Factors

PHILADELPHIA — (April 1, 2021) — Scientists at The Wistar Institute identified a new mechanism of transcriptional control of cellular senescence that drives the release of inflammatory molecules that influence tumor development through altering the…
Read more
|

Richard M. Horowitz Appointed Chair of The Wistar Institute’s Board of Trustees

PHILADELPHIA — (March 23, 2021) — The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to announce the appointment of Richard M. Horowitz as chair of its Board of Trustees. Horowitz, w…
Read more
|

Dr. Katelyn Miller Awarded American Cancer Society Fellowship

Katelyn Miller, Ph.D., postdoctoral fellow in the Wistar lab of Dr. Zach Schug, is the recipient of the prized Rena and Victor Damone Postdoctoral Fellowship in Cancer Research from the American Cancer Society (ACS). Awarded through the Extramural D…
Read more
|

RNA Editing Protein ADAR1 Protects Telomeres and Supports Proliferation in Cancer Cells

PHILADELPHIA — (March 12, 2021) — Scientists at The Wistar Institute identified a new function of ADAR1, a protein responsible for RNA editing, discovering that the ADAR1p110 isoform regulates genome stability at chromosome ends and is required for…
Read more